Optical coherent tomography capabilities in the diagnosis of demyelinating diseases of the central nervous system

Cover Page

Cite item

Full Text


Optical coherence tomography (OCT) is a non-invasive technique routinely used for obtaining in vivo transverse images of tissues. In the field of neurology, OCT is used to assess retinal changes in various diseases, including multiple sclerosis, opticomyelitis, and opticomyelitis-associated disorders. In these demyelinating diseases, the pathological process involves not only the optic nerve itself, but also the retinal ganglion cells and their axons, the so-called retinal ganglionic complex, as well as the retinal nerve fiber layer. In the last decade, OCT as the method capable of assessing changes in the above-mentioned retinal layers has been applied as a highly sensitive technology for estimation of neurodegenerative process. The article discusses the possible use of OCT for differential diagnosis of demyelinating diseases of the central nervous system, as well as its application as a method for monitoring involvement of the nervous tissue in demyelinating diseases.

About the authors

Natalia V. Polekhina

Research Center of Neurology

Author for correspondence.
Email: natalie.polekhina@gmail.com
Russian Federation, Moscow

Zoya V. Surnina

Research Institute of Eye Diseases

Email: natalie.polekhina@gmail.com
Russian Federation, Moscow

Maria N. Zakharova

Research Center of Neurology

Email: natalie.polekhina@gmail.com
Russian Federation, Moscow


  1. Lumbroso B., Rispoli M. OKT setchatki. Metod analiza i interpretatsii [OCT of the retina. Method of analysis and interpretation]. V.V. Neroev, O.V. Zaitseva (eds.). Moscow: Aprel’; 2012. 83 р. (In Russ.)
  2. Saidha S., Al-Louzi O., Ratchford J. et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol 2015; 78: 801–813. doi: 10.1002/ana.24487. PMID: 26190464.
  3. Caruana P., Davies M., Weatherby S. et al. Correlation of MRI lesions with visual psychophysical deficit in secondary progressive multiple sclerosis. Brain 2000; 123: 1471-1480. PMID: 10869058.
  4. Noval S., Contreras I., Muñoz S. et al. Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update. Mult Scler Int 2011; 2011: 472790. doi: 10.1155/2011/472790. PMID: 22096638.
  5. Parisi V., Manni G., Spadaro M. et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40: 2520–2527. PMID: 10509645.
  6. McDonald W., Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 1992; 55: 747–752. PMID: 1402963.
  7. La Morgia C., Barboni P., Rizzo G. et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 2013; 20: 198–201. doi: 10.1111/j.1468-1331.2012.03701.x. PMID: 22436028.
  8. de Seze J., Blanc F., Jeanjean L. et al. Optical coherence tomography in neuromyelitis optica. Arch Neurol 2008; 65: 920–923. doi: 10.1001/archneur.65.7.920. PMID: 18625858.
  9. Lennon V., Wingerchuk D., Kryzer T. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112. doi: 10.1016/S0140-6736(04)17551-X. PMID: 15589308.
  10. Naismith R., Tutlam N., Xu J. et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009; 72: 1077–1082. doi: 10.1212/01.wnl.0000345042.53843.d5. PMID: 19307541.
  11. Nakamura M., Nakazawa T., Doi H. et al. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol 2010; 248: 1777–1785. doi: 10.1007/s00417-010-1344-7. PMID: 20300766.
  12. Merle H., Olindo S., Donnio A. et al. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 2008; 49: 4412–4417. doi: 10.1167/iovs.08-1815. PMID: 18614811.
  13. Costello F., Coupland S., Hodge W. et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963–969. doi: 10.1002/ana.20851. PMID: 16718705.
  14. Costello F., Hodge W., Pan Y. et al. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler 2008; 14: 893–905. doi: 10.1177/1352458508091367. PMID: 18573837.
  15. Outteryck O., Zephir H., Defoort S. et al. Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. Arch Neurol 2009; 66: 1373–1377. doi: 10.1001/archneurol.2009.265. PMID: 19901169.
  16. Grazioli E., Zivadinov R., Weinstock-Guttman B. et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008; 268: 12–17. doi: 10.1016/j.jns.2007.10.020. PMID: 18054962.
  17. Klistorner A., Arvind H., Nguyen T. et al. Axonal loss and myelin in early on loss in postacute optic neuritis. Ann Neurol 2008; 64: 325–331. doi: 10.1002/ana.21474. PMID: 18825673.
  18. Siger M., Dziegielewski K., Jasek L. et al. Optical coherence tomography inmultiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol 2008; 255: 1555–1560. doi: 10.1007/s00415-008-0985-5. PMID: 18825432.
  19. Fisher J.B., Jacobs D.A. Markowitz C.E. et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324–332. doi: 10.1016/j.ophtha.2005.10.040. PMID: 16406539.
  20. Trip S., Schlottmann P., Jones S. et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58: 383–391. doi: 10.1002/ana.20575. PMID: 16075460.
  21. Siepman T., Bettink-Remeijer M., Hintzen R. Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry. J Neurol 2010; 257: 1654–1660. doi: 10.1007/s00415-010-5589-1. PMID: 20461397.
  22. Khanifar A., Parlitsis G., Ehrlich J. et al. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol 2010; 4: 1007–1013. PMID: 20922034.
  23. Burkholder B., Osborne B. Loguidice M. et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol 2009; 66: 1366–1372. doi: 10.1001/archneurol.2009.230. PMID: 19901168.
  24. Bertuzzi F., Suzani V., Tagliabue E. et al. Diagnostic validity of optic disc and retinal nerve fiber layer evaluations in detecting structural changes after optic neuritis. Ophthalmology 2010; 117: 1256–1264. doi: 10.1016/j.ophtha.2010.02.024. PMID: 20381872.
  25. Khanifar G., Parlitsis G., Ehrlich J. et al. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol 2010; 4: 1007–1013. PMID: 20922034.
  26. Costello F., Hodge W., Pan Y. et al. Using retinal architecture to help characterize multiple sclerosis patients. Can J Ophthalmol 2010; 45: 520–526. doi: 10.3129/i10-063. PMID: 20838421.
  27. Gordon-Lipkin E., Chodkowski B., Reich D. et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69: 1603–1609. doi: 10.1212/01.wnl.0000295995.46586.ae. PMID: 17938370.
  28. Frohman E., Dwyer M., Frohman T. et al. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci 2009; 282: 96–105. doi: 10.1016/j.jns.2009.04.010. PMID: 19439327.
  29. Eliseeva E.K. [Inflammatory and demyelinating optical neuritis: clinical and functional study. Thesis for a Candidate Degree in Medical Sciences]. Moscow; 2017. (In Russ.)
  30. Neroev V.V., Eliseeva E.K., Zueva M.V. et al. [Demyelinating optical neuritis: correlation of data of optical coherence tomography and multifocal electroretinography]. Annals of clinical and experimental neurology 2014; 8(2): 22–26. (In Russ.)
  31. Eliseeva E.K., Neroev V.V., Zueva M.V. et al. [Optical neuritis in multiple sclerosis (literature review and results of author’s research)]. Tochka zreniya. Vostok–Zapad 2018; (2): 112–115. doi: 10.25276/2410-1257-2018-2-112-115. (In Russ.)

Supplementary files

Supplementary Files

Copyright (c) 2018 Polekhina N.V., Surnina Z.V., Zakharova M.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies